Skip to main content

Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.

Publication ,  Journal Article
Armstrong, PW; Collen, D
Published in: Circulation
June 12, 2001

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

June 12, 2001

Volume

103

Issue

23

Start / End Page

2862 / 2866

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Recombinant Proteins
  • Myocardial Reperfusion
  • Myocardial Infarction
  • Metabolic Clearance Rate
  • Humans
  • Hemorrhage
  • Fibrinolytic Agents
  • Fibrin
  • Dose-Response Relationship, Drug
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., & Collen, D. (2001). Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Circulation, 103(23), 2862–2866. https://doi.org/10.1161/01.cir.103.23.2862
Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.Circulation 103, no. 23 (June 12, 2001): 2862–66. https://doi.org/10.1161/01.cir.103.23.2862.
Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.Circulation, vol. 103, no. 23, June 2001, pp. 2862–66. Pubmed, doi:10.1161/01.cir.103.23.2862.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

June 12, 2001

Volume

103

Issue

23

Start / End Page

2862 / 2866

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Recombinant Proteins
  • Myocardial Reperfusion
  • Myocardial Infarction
  • Metabolic Clearance Rate
  • Humans
  • Hemorrhage
  • Fibrinolytic Agents
  • Fibrin
  • Dose-Response Relationship, Drug